USPTO Rescinds Controversial Patent Rule Changes Proposed by Prior Administration | GenomeWeb

NEW YORK (GenomeWeb Daily News) – The US Patent and Trademark Office said yesterday that Under Secretary of Commerce for Intellectual Property and Director David Kappos has signed a final rule rescinding highly controversial regulations that were enacted by the USPTO under the Bush administration and were viewed by many in the biotech industry as hindering their ability to protect IP.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.